In the BioHarmony Drug Report Database
Radium ra-223
Xofigo (radium ra-223) is a small molecule pharmaceutical. Radium ra-223 was first approved as Xofigo on 2013-05-15. Xofigo’s patent is valid until 2022-11-17 (FDA).
Trade Name
|
Xofigo |
|---|---|
Common Name
|
radium ra-223 |
ChEMBL ID
|
CHEMBL4297420 |
Indication
|
|
Drug Class
|
Quaternary ammonium derivatives |
Image (chem structure or protein)